title: [Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Hosoya
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Okada
authors.forename: Masaru
authors.initials: M
authors.lastname: Horio
authors.forename: Iwao
authors.initials: I
authors.lastname: Ohno
authors.forename: Shozo
authors.initials: S
authors.lastname: Tamura
authors.forename: Hideharu
authors.initials: H
authors.lastname: Sugimoto
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Tsushima
authors.forename: Hiromitsu
authors.initials: H
authors.lastname: Hayashi
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Fukuda
authors.forename: Yukunori
authors.initials: Y
authors.lastname: Korogi
authors.forename: Narumi
authors.initials: N
authors.lastname: Yoshifumi
mesh_terms: D000075202:Contraindications; D003287:Contrast Media / Q000008:administration & dosage* / Q000009:adverse effects; D005682:Gadolinium / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D003287:Contrast Media; D005682:Gadolinium